top of page
Search

Doctor explains: What is the SequenceME Study? What the UK's New £4.75M Genomics Project Means for Patients

For many years, people living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) have asked the same question: Why does this illness happen? Researchers have made progress, but many important questions remain unanswered.

A major new UK research project called SequenceME hopes to help answer some of those questions. Building on the earlier DecodeME study, researchers will analyse the DNA of thousands of people with ME/CFS to better understand the biological causes of the illness.

As an ME/CFS specialist, I am often asked whether this research will lead to better diagnosis, improved ME/CFS testing, or new treatments. While no single study provides all the answers, SequenceME is a step towards a better understanding of this complex condition.

Why is Post-Exertional Malaise (PEM) so important?

One of the defining symptoms of ME/CFS is Post-Exertional Malaise (PEM).

Unlike ordinary tiredness, Post-Exertional Malaise (PEM) is a worsening of symptoms after physical, mental or emotional activity that would not previously have caused problems. Symptoms often worsen hours later or even the following day, and recovery may take days, weeks, or longer.

Because Post-Exertional Malaise (PEM) is such a key feature of ME/CFS, it helps distinguish the illness from many other causes of fatigue.

Understanding why Post-Exertional Malaise (PEM) occurs is one of the biggest priorities for researchers. Studies such as SequenceME may eventually identify biological pathways that contribute to this unique symptom.

What was the DecodeME study?

Before SequenceME, the UK's largest genetics project for ME/CFS was DecodeME.

DecodeME recruited tens of thousands of people across the UK who had been diagnosed with ME/CFS. Researchers collected saliva samples to investigate whether certain genetic differences are more common in people with the condition.

Early findings have already identified several genetic regions that deserve further investigation. These results suggest that ME/CFS is associated with biological processes involving the immune system and cellular function, rather than being solely caused by deconditioning or psychological factors.

However, genetic associations do not prove cause and effect. Instead, they provide valuable clues that guide future research.

What is the SequenceME Study?

SequenceME is the next stage of UK ME/CFS genetics research.

Supported by approximately £4.75 million in funding, the project plans to conduct detailed DNA sequencing of around 6,000 people with ME/CFS. Rather than looking only at common genetic markers, researchers will examine the full sequence of many genes to identify rarer genetic variations that may contribute to illness.

This deeper level of analysis allows scientists to investigate:

  • genes involved in immune regulation

  • energy production within cells

  • inflammation

  • nervous system function

  • responses to viral infections

Researchers hope these findings will improve understanding of why some people develop ME/CFS following infections while others recover completely.

How could Post-Exertional Malaise (PEM) research benefit patients?

Many patients tell me that Post-Exertional Malaise (PEM) is the symptom that affects their daily life the most.

Although we already recognise Post-Exertional Malaise (PEM) clinically, we still lack a laboratory test to confirm its cause.

If researchers discover biological mechanisms behind Post-Exertional Malaise (PEM), this could eventually lead to:

  • improved ME/CFS testing

  • better diagnostic accuracy

  • new drug targets

  • personalised ME/CFS therapy

  • more effective monitoring of disease severity

These developments are unlikely to happen overnight, but each study brings us closer.

Will SequenceME lead to better ME/CFS testing?

Many patients hope that DNA research will quickly produce a simple blood test.

Unfortunately, research rarely progresses that quickly. It is also worth keeping in mind that people are not born with ME/CFS but acquire it during their lifetime.

Although SequenceME may identify genetic risk factors, genetics alone is unlikely to explain every case of ME/CFS. Most experts believe the illness develops through a combination of genetic susceptibility, infections, immune responses, and environmental factors (such as stress).

Future ME/CFS testing may combine genetic information with blood biomarkers, immune markers and clinical assessment to improve diagnostic accuracy.

At present, diagnosis remains based primarily on a detailed medical history, careful examination and exclusion of alternative conditions.

Can SequenceME improve ME/CFS therapy?

Patients understandably ask whether this research means a cure is coming.

The honest answer is that no one knows yet.

However, understanding the biological mechanisms behind ME/CFS is an essential step towards developing better ME/CFS therapy. Modern medicine has seen this pattern before in many diseases. Researchers first identify biological pathways, then develop targeted treatments years later.

Although SequenceME is not a treatment study, it provides important information that may guide future clinical trials.

What does this mean for people with Long COVID?

Many people attending a Long COVID fatigue clinic experience symptoms that closely resemble ME/CFS, particularly Post-Exertional Malaise (PEM).

Research suggests there may be an overlap between post-viral illnesses, although they are not necessarily identical conditions.

Because SequenceME investigates biological pathways involved in ME/CFS, some discoveries may also improve understanding of persistent symptoms following COVID-19 and other viral infections.

This is one reason why research into ME/CFS has become increasingly important.

Why specialist assessment still matters

Research is exciting, but it does not replace careful clinical assessment.

An experienced ME/CFS specialist or online ME/CFS doctor can assess symptoms, identify Post-Exertional Malaise (PEM), investigate alternative diagnoses and discuss current evidence-based management strategies.

Many patients also have overlapping conditions such as fibromyalgia. In these situations, assessment by an online fibromyalgia specialist or a post-viral fatigue doctor may help clarify which symptoms relate to each condition.

Specialist assessment can also provide practical advice about pacing, symptom management, activity planning and appropriate investigations while research continues.

As new discoveries emerge from ME/CFS research, they may eventually improve both diagnosis and treatment, but patients should continue to receive personalised care based on current medical knowledge.

Learn more

If you would like to learn more about specialist assessment and current approaches to ME/CFS research, ME/CFS testing, and ME/CFS therapy, you may find these pages helpful:

If you would like a specialist assessment, learn more about our online consultations.

 
 
 

Comments

bottom of page